Kewaunee Scientific Co. (NASDAQ:KEQU) Short Interest Update

Kewaunee Scientific Co. (NASDAQ:KEQU) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 9,900 shares, a growth of 23.8% from the March 15th total of 8,000 shares. Approximately 0.5% of the company’s shares are sold short. Based on an average daily trading volume, of 6,500 shares, the short-interest ratio is currently 1.5 days.

Insider Activity

In other news, VP Elizabeth D. Phillips sold 3,277 shares of Kewaunee Scientific stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $32.50, for a total value of $106,502.50. Following the completion of the sale, the vice president now directly owns 10,263 shares of the company’s stock, valued at approximately $333,547.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, VP Elizabeth D. Phillips sold 3,277 shares of Kewaunee Scientific stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $32.50, for a total transaction of $106,502.50. Following the completion of the sale, the vice president now directly owns 10,263 shares of the company’s stock, valued at $333,547.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Douglas J. Batdorff sold 3,500 shares of Kewaunee Scientific stock in a transaction on Friday, March 15th. The stock was sold at an average price of $31.35, for a total value of $109,725.00. Following the sale, the vice president now directly owns 6,167 shares of the company’s stock, valued at $193,335.45. The disclosure for this sale can be found here. Insiders own 14.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its holdings in shares of Kewaunee Scientific by 58.2% in the second quarter. BlackRock Inc. now owns 13,102 shares of the technology company’s stock valued at $198,000 after purchasing an additional 4,822 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Kewaunee Scientific by 0.7% in the second quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company’s stock valued at $1,631,000 after purchasing an additional 700 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Kewaunee Scientific by 1.3% in the first quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company’s stock valued at $1,836,000 after purchasing an additional 1,683 shares in the last quarter. Minerva Advisors LLC lifted its holdings in shares of Kewaunee Scientific by 0.9% in the third quarter. Minerva Advisors LLC now owns 174,432 shares of the technology company’s stock valued at $2,843,000 after purchasing an additional 1,513 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Kewaunee Scientific by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company’s stock valued at $3,273,000 after purchasing an additional 742 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on KEQU shares. TheStreet cut Kewaunee Scientific from a “b-” rating to a “c” rating in a research note on Thursday, March 7th. StockNews.com raised Kewaunee Scientific from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th.

Kewaunee Scientific Trading Up 1.9 %

KEQU stock traded up $0.65 during midday trading on Monday, hitting $34.85. 8,349 shares of the company’s stock were exchanged, compared to its average volume of 6,584. The stock’s fifty day moving average price is $31.25 and its 200-day moving average price is $25.46. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.76 and a current ratio of 2.28. The company has a market cap of $99.32 million, a PE ratio of 11.69 and a beta of 0.69. Kewaunee Scientific has a one year low of $14.56 and a one year high of $36.86.

Kewaunee Scientific (NASDAQ:KEQU) last posted its earnings results on Wednesday, March 6th. The technology company reported $0.85 earnings per share for the quarter. The firm had revenue of $46.78 million for the quarter. Kewaunee Scientific had a return on equity of 20.82% and a net margin of 4.34%.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.